Objective
A lot of efforts is being put lately on the development of active wound care products.
The use of keratin in dressings for dermal injury (such as a burn injury) could support skin reconstruction and would healing. However, so far this has not been possible due to: 1) the low quality of the hydrolyzed keratin extracted so far that make it useless and ineffective in biomedical formulations; 2) the hydrophobic solvents used make it impossible to mix the keratin in water-based formulations and to produce nanofibers through electrospinning.
KerLine has a ready-to-patent proprietary method to fabricate nanofibrous dressings for biomedical applications through electrospinning technique starting from hydrosoluble keratin and active ingredients in water solution (SkinKer dressings). This has been so far never possible because water insoluble keratin cannot be electrospun. Kerline technology offer an outstanding technological and manufacturing advantage as respect to competitors as it allows to fabricate safer, cost-effective and advantageous SkinKer dressings. In addition, SkinKer dressings offer: i) a complete coverage of the injured tissue adhesion; ii) a protection against infections and dehydration with air permeation and iii) the delivery of drugs (e.g. antioxidant, anti-inflammatory and antimicrobial agents) to the wound.
KerLine aims to produce electrospun SkinKer dressings for the biomedical sectors and sell customized products by reaching B2B licenses and commercial agreements with companies operating in the field of biomedical devices for skin reconstruction and wound healing. Kerline aims to become a market leader in natural biomaterials used for biomedical applications by substituting inert biomaterials with the natural and multifunctional properties of hydrosoluble keratin.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- engineering and technology materials engineering fibers
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- social sciences economics and business business and management business models
- engineering and technology industrial biotechnology biomaterials
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
40129 BOLOGNA
Italy
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.